Cognitive stimulation in the workplace, plasma proteins, and risk of dementia: three analyses of population cohort studies
Open accessAbstract
Objectives: To examine the association between cognitively stimulating work and subsequent risk of dementia and to identify protein pathways for this association. Design: Multicohort study with three sets of analyses. Setting: United Kingdom, Europe, and the United States. Participants: Three associations were examined: cognitive stimulation and dementia risk in 107 896 participants from seven population based prospective cohort studies from the IPD-Work consortium (individual participant data meta-analysis in working populations); cognitive stimulation and proteins in a random sample of 2261 participants from one cohort study; and proteins and dementia risk in 13 656 participants from two cohort studies. Main outcome measures: Cognitive stimulation was measured at baseline using standard questionnaire instruments on active versus passive jobs and at baseline and over time using a job exposure matrix indicator. 4953 proteins in plasma samples were scanned. Follow-up of incident dementia varied between 13.7 to 30.1 years depending on the cohort. People with dementia were identified through linked electronic health records and repeated clinical examinations. Results: During 1.8 million person years at risk, 1143 people with dementia were recorded. The risk of dementia was found to be lower for participants with high compared with low cognitive stimulation at work (crude incidence of dementia per 10 000 person years 4.8 in the high stimulation group and 7.3 in the low stimulation group, age and sex adjusted hazard ratio 0.77, 95% confidence interval 0.65 to 0.92, heterogeneity in cohort specific estimates I 2 =0%, P=0.99). This association was robust to additional adjustment for education, risk factors for dementia in adulthood (smoking, heavy alcohol consumption, physical inactivity, job strain, obesity, hypertension, and prevalent diabetes at baseline), and cardiometabolic diseases (diabetes, coronary heart disease, stroke) before dementia diagnosis (fully adjusted hazard ratio 0.82, 95% confidence interval 0.68 to 0.98). The risk of dementia was also observed during the first 10 years of follow-up (hazard ratio 0.60, 95% confidence interval 0.37 to 0.95) and from year 10 onwards (0.79, 0.66 to 0.95) and replicated using a repeated job exposure matrix indicator of cognitive stimulation (hazard ratio per 1 standard deviation increase 0.77, 95% confidence interval 0.69 to 0.86). In analysis controlling for multiple testing, higher cognitive stimulation at work was associated with lower levels of proteins that inhibit central nervous system axonogenesis and synaptogenesis: slit homologue 2 (SLIT2, fully adjusted β −0.34, P<0.001), carbohydrate sulfotransferase 12 (CHSTC, fully adjusted β −0.33, P<0.001), and peptidyl-glycine α-amidating monooxygenase (AMD, fully adjusted β −0.32, P<0.001). These proteins were associated with increased dementia risk, with the fully adjusted hazard ratio per 1 SD being 1.16 (95% confidence interval 1.05 to 1.28) for SLIT2, 1.13 (1.00 to 1.27) for CHSTC, and 1.04 (0.97 to 1.13) for AMD. Conclusions: The risk of dementia in old age was found to be lower in people with cognitively stimulating jobs than in those with non-stimulating jobs. The findings that cognitive stimulation is associated with lower levels of plasma proteins that potentially inhibit axonogenesis and synaptogenesis and increase the risk of dementia might provide clues to underlying biological mechanisms.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
High cognitive stimulation at work is associated with lower dementia risk compared with low cognitive stimulation at work (HR 0.79, 0.66-0.95).
“A study of 107,896 people from HICs followed for 13.7-30.1 years found a lower risk of dementia in participants with high compared with low cognitive stimulation at work (10-year follow-up HR= 0.79, 0.66 -0.95).”
From Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission (2024) · cites this paper as [74]
The Results report follow-up ranging from 13.7 to 30.1 years, and Table 2 totals 107,896 participants. The Abstract Results report lower dementia risk with high versus low workplace cognitive stimulation and give HR 0.79 (95% CI 0.66–0.95), but that estimate applies from year 10 onward, not to the first 10 years of follow-up (HR 0.60). Page numbers are unavailable in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
Dementia prevention, intervention, and care: 2020 report of the Lancet Commission
Livingston, G., Huntley, J., Sommerlad, A., Ames, D., Ballard, C., Banerjee, S., Brayne, C., Burns, A., Cohen-Mansfield, J., Cooper, C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30367-6 · Cited by 10,430 · see citing works
Self-citationRetractedAptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015004 · Cited by 1,754 · see citing works
Inequalities in dementia incidence between six racial and ethnic groups over 14 years
Mayeda, E. R., Glymour, M. M., Quesenberry, C. P., & Whitmer, R. A. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.12.007 · Cited by 883 · see citing works
Timing of onset of cognitive decline: results from Whitehall II prospective cohort study
Singh-Manoux, A., Kivimaki, M., Glymour, M. M., Elbaz, A., Berr, C., Ebmeier, K. P., Ferrie, J. E., & Dugravot, A. (2012) · BMJ · doi:10.1136/bmj.d7622 · Cited by 836 · see citing works
Self-citationDoes Cognitive Training Prevent Cognitive Decline?: A Systematic Review
Butler, M., McCreedy, E., Nelson, V. A., Desai, P., Ratner, E., Fink, H. A., Hemmy, L. S., McCarten, J. R., Barclay, T. R., Brasure, M., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m17-1531 · Cited by 236 · see citing works
Selective Neuronal Vulnerability in Alzheimer’s Disease: A Network-Based Analysis
Roussarie, J.-P., Yao, V., Rodriguez-Rodriguez, P., Oughtred, R., Rust, J., Plautz, Z., Kasturia, S., Albornoz, C., Wang, W., Schmidt, E. F., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.010 · Cited by 180 · see citing works
Brain ageing changes proteoglycan sulfation, rendering perineuronal nets more inhibitory
Foscarin, S., Raha-Chowdhury, R., Fawcett, J. W., & Kwok, J. C. F. (2017) · Aging · doi:10.18632/aging.101256 · Cited by 139 · see citing works
Effect of smoking cessation on the risk of dementia: a longitudinal study
Choi, D., Choi, S., & Park, S. M. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.633 · Cited by 134 · see citing works
Staff, R. T., Hogan, M. J., Williams, D. S., & Whalley, L. J. (2018) · BMJ · doi:10.1136/bmj.k4925 · Cited by 98 · see citing works
Cognitive and social activities and long-term dementia risk: the prospective UK Million Women Study
Floud, S., Balkwill, A., Sweetland, S., Brown, A., Reus, E. M., Hofman, A., Blacker, D., Kivimaki, M., Green, J., Peto, R., et al. (2021) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30284-x · Cited by 83 · see citing works
Gates, N. J., Rutjes, A. W., Di Nisio, M., Karim, S., Chong, L.-Y., March, E., Martínez, G., & Vernooij, R. W. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012278.pub2 · Cited by 46 · see citing works
Dang, C., Harrington, K. D., Lim, Y. Y., Ames, D., Hassenstab, J., Laws, S. M., Yassi, N., Hickey, M., Rainey-Smith, S., Robertson, J., et al. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180507 · Cited by 31 · see citing works
Flagged first, then by citations
Research works printed but not linked: 36
- [2]Smart EL Gow AJ Deary IJ. Occupational complexity and lifetime cognitive abilities. Neurology 2014; 83: 2285- 91. 10.1212/WNL.0000000000001075. 25411439 PMC4277669 · DOI
- [3]Andel R Kåreholt I Parker MG Thorslund M Gatz M. Complexity of primary lifetime occupation and cognition in advanced old age. J Aging Health 2007; 19: 397- 415. 10.1177/0898264307300171. 17496241 · DOI
- [6]Gavelin HM Lampit A Hallock H Sabatés J Bahar-Fuchs A. Cognition-oriented treatments for older adults: a systematic overview of systematic reviews. Neuropsychol Rev 2020; 30: 167- 93. 10.1007/s11065-020-09434-8. 32266520 PMC7305099 · DOI
- [7]Sommerlad A Sabia S Livingston G Kivimäki M Lewis G Singh-Manoux A. Leisure activity participation and risk of dementia: An 18-year follow-up of the Whitehall II Study. Neurology 2020; 95: e2803- 15. 10.1212/WNL.0000000000010966. 33115773 PMC7734721 · DOI · Paper page
- [9]Almeida-Meza P Steptoe A Cadar D. Markers of cognitive reserve and dementia incidence in the English Longitudinal Study of Ageing. Br J Psychiatry 2020; 218: 1- 9. 10.1192/bjp.2020.54. 32223764 PMC7529639 · DOI
- [10]Karasek RA. Job demands, job decision latitude and mental strain: implications for job redesign. Adm Sci Q 1979; 24: 285- 307 10.2307/2392498. · DOI · Paper page
- [12]Huang LY Hu HY Wang ZT. Association of occupational factors and dementia or cognitive impairment: a systematic review and meta-analysis. J Alzheimers Dis 2020; 78: 217- 27. 10.3233/JAD-200605. 32986670 · DOI
- [13]Fratiglioni L Marseglia A Dekhtyar S. Ageing without dementia: can stimulating psychosocial and lifestyle experiences make a difference? Lancet Neurol 2020; 19: 533- 43. 10.1016/S1474-4422(20)30039-9. 32470425 · DOI
- [14]Kivimäki M Nyberg ST Batty GD IPD-Work Consortium. Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data. Lancet 2012; 380: 1491- 7. 10.1016/S0140-6736(12)60994-5. 22981903 PMC3486012 · DOI
- [15]Williams SA Kivimaki M Langenberg C. Plasma protein patterns as comprehensive indicators of health. Nat Med 2019; 25: 1851- 7. 10.1038/s41591-019-0665-2. 31792462 PMC6922049 · DOI · Paper page
- [16]Emilsson V Ilkov M Lamb JR. Co-regulatory networks of human serum proteins link genetics to disease. Science 2018; 361: 769- 73. 10.1126/science.aaq1327. 30072576 PMC6190714 · DOI · Paper page
- [17]Sun BB Maranville JC Peters JE. Genomic atlas of the human plasma proteome. Nature 2018; 558: 73- 9. 10.1038/s41586-018-0175-2. 29875488 PMC6697541 · DOI · Paper page
- [18]Gottesman RF Schneider AL Albert M. Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study. JAMA Neurol 2014; 71: 1218- 27. 10.1001/jamaneurol.2014.1646. 25090106 PMC4226067 · DOI · Paper page
- [19]Fransson EI Nyberg ST Heikkilä K. Comparison of alternative versions of the job demand-control scales in 17 European cohort studies: the IPD-Work consortium. BMC Public Health 2012; 12: 62. 10.1186/1471-2458-12-62. 22264402 PMC3328260 · DOI
- [20]Kivimäki M Singh-Manoux A Pentti J IPD-Work consortium. Physical inactivity, cardiometabolic disease, and risk of dementia: an individual-participant meta-analysis. BMJ 2019; 365: l1495. 10.1136/bmj.l1495. 30995986 PMC6468884 · DOI · Paper page
- [21]Mielke MM Vemuri P Rocca WA. Clinical epidemiology of Alzheimer’s disease: assessing sex and gender differences. Clin Epidemiol 2014; 6: 37- 48. 10.2147/CLEP.S37929. 24470773 PMC3891487 · DOI · Paper page
- [24]Williamson JD Pajewski NM Auchus AP SPRINT MIND Investigators for the SPRINT Research Group. Effect of intensive vs standard blood pressure control on probable dementia: A randomized clinical trial. JAMA 2019; 321: 553- 61. 10.1001/jama.2018.21442. 30688979 PMC6439590 · DOI
- [26]Chatterjee S Peters SA Woodward M. Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia. Diabetes Care 2016; 39: 300- 7. 10.2337/dc15-1588. 26681727 PMC4722942 · DOI · Paper page
- [27]Kivimäki M Nyberg ST Pentti J IPD-Work consortium. Individual and combined effects of job strain components on subsequent morbidity and mortality. Epidemiology 2019; 30: e27- 9. 10.1097/EDE.0000000000001020. 30985532 · DOI
- [28]Kim CH Tworoger SS Stampfer MJ. Stability and reproducibility of proteomic profiles measured with an aptamer-based platform. Sci Rep 2018; 8: 8382. 10.1038/s41598-018-26640-w. 29849057 PMC5976624 · DOI · Paper page
- [29]Candia J Cheung F Kotliarov Y. Assessment of variability in the SOMAscan assay. Sci Rep 2017; 7: 14248. 10.1038/s41598-017-14755-5. 29079756 PMC5660188 · DOI
- [31]Sommerlad A Perera G Singh-Manoux A Lewis G Stewart R Livingston G. Accuracy of general hospital dementia diagnoses in England: Sensitivity, specificity, and predictors of diagnostic accuracy 2008-2016. Alzheimers Dement 2018; 14: 933- 43. 10.1016/j.jalz.2018.02.012. 29703698 PMC6057268 · DOI
- [32]Wilkinson T Ly A Schnier C UK Biobank Neurodegenerative Outcomes Group and Dementias Platform UK. Identifying dementia cases with routinely collected health data: A systematic review. Alzheimers Dement 2018; 14: 1038- 51. 10.1016/j.jalz.2018.02.016. 29621480 PMC6105076 · DOI · Paper page
- [33]Wilkinson T Schnier C Bush K Dementias Platform UK and UK Biobank. Identifying dementia outcomes in UK Biobank: a validation study of primary care, hospital admissions and mortality data. Eur J Epidemiol 2019; 34: 557- 65. 10.1007/s10654-019-00499-1. 30806901 PMC6497624 · DOI · Paper page
- [34]Barlett JW Morris TB. Multiple imputation of covariates by substantive-model compatible fully conditional specification. Stata J 2015; 15: 437- 56 10.1177/1536867X1501500206. · DOI
- [35]Fine JP Gray RJ. A Proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496- 509 10.1080/01621459.1999.10474144. · DOI · Paper page
- [37]Then FS Luck T Luppa M. Systematic review of the effect of the psychosocial working environment on cognition and dementia. Occup Environ Med 2014; 71: 358- 65. 10.1136/oemed-2013-101760. 24259677 · DOI
- [39]Wang HX Wahlberg M Karp A Winblad B Fratiglioni L. Psychosocial stress at work is associated with increased dementia risk in late life. Alzheimers Dement 2012; 8: 114- 20. 10.1016/j.jalz.2011.03.001. 22404853 · DOI
- [40]World Health Organization. Risk reduction of cognitive decline and dementia: WHO guidelines. WHO, 2019. 31219687
- [41]Anderson EL Howe LD Wade KH. Education, intelligence and Alzheimer’s disease: evidence from a multivariable two-sample Mendelian randomization study. Int J Epidemiol 2020; 49: 1163- 72. 10.1093/ije/dyz280. 32003800 PMC7660137 · DOI
- [42]Lin L Isacson O. Axonal growth regulation of fetal and embryonic stem cell-derived dopaminergic neurons by Netrin-1 and Slits. Stem Cells 2006; 24: 2504- 13. 10.1634/stemcells.2006-0119. 16840550 PMC2613222 · DOI
- [43]Brose K Bland KS Wang KH. Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance. Cell 1999; 96: 795- 806. 10.1016/S0092-8674(00)80590-5. 10102268 · DOI
- [44]Sobota JA Mohler WA Cowan AE Eipper BA Mains RE. Dynamics of peptidergic secretory granule transport are regulated by neuronal stimulation. BMC Neurosci 2010; 11: 32. 10.1186/1471-2202-11-32. 20202202 PMC2838897 · DOI
- [45]Nguyen Ba-Charvet KT Brose K Marillat V. Slit2-mediated chemorepulsion and collapse of developing forebrain axons. Neuron 1999; 22: 463- 73. 10.1016/S0896-6273(00)80702-3. 10197527 · DOI
- [47]Kwok JC Warren P Fawcett JW. Chondroitin sulfate: a key molecule in the brain matrix. Int J Biochem Cell Biol 2012; 44: 582- 6. 10.1016/j.biocel.2012.01.004. 22265655 · DOI
- [48]Silver J Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci 2004; 5: 146- 56. 10.1038/nrn1326. 14735117 · DOI
Cited by
Sorted by citations
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
Livingston, G., Huntley, J., Liu, K. Y., Costafreda, S. G., Selbæk, G., Alladi, S., Ames, D., Banerjee, S., Burns, A., Brayne, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01296-0 · Cited by 3,860 · see citing works
Self-citationSocial participation and risk of developing dementia
Sommerlad, A., Kivimäki, M., Larson, E. B., Röhr, S., Shirai, K., Singh-Manoux, A., & Livingston, G. (2023) · Nature Aging · doi:10.1038/s43587-023-00387-0 · Cited by 207 · see citing works
Self-citationLife course epidemiology and public health
Wagner, C., Carmeli, C., Jackisch, J., Kivimäki, M., van der Linden, B. W. A., Cullati, S., & Chiolero, A. (2024) · The Lancet Public Health · doi:10.1016/s2468-2667(24)00018-5 · Cited by 188 · see citing works
Ma, L.-Z., Zhang, Y.-R., Li, Y.-Z., Ou, Y.-N., Yang, L., Chen, S.-D., Dong, Q., Feng, J.-F., Cheng, W., Tan, L., et al. (2023) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.06.005 · Cited by 46 · see citing works
Sex/gender and socioeconomic differences in modifiable risk factors for dementia
Geraets, A. F. J., & Leist, A. K. (2023) · Scientific Reports · doi:10.1038/s41598-022-27368-4 · Cited by 43 · see citing works
Bloomberg, M., Dugravot, A., Sommerlad, A., Kivimäki, M., Singh-Manoux, A., & Sabia, S. (2023) · Age and Ageing · doi:10.1093/ageing/afad019 · Cited by 34 · see citing works
Self-citation
- Authors
- Kivimäki, M., Walker, K. A., Pentti, J., Nyberg, S. T., Mars, N., Vahtera, J., Suominen, S. B., Lallukka, T., Rahkonen, O., Pietiläinen, O., Koskinen, A., Väänänen, A., Kalsi, J. K., Goldberg, M., Zins, M., Alfredsson, L., Westerholm, P. J. M., Knutsson, A., Theorell, T., Ervasti, J., Oksanen, T., Sipilä, P. N., Tabak, A. G., Ferrie, J. E., Williams, S. A., Livingston, G., Gottesman, R. F., Singh-Manoux, A., Zetterberg, H., & Lindbohm, J. V.
- Affiliations
- Johns Hopkins University (US)
- University of Helsinki (FI)
- University of Turku (FI)
- Finnish Institute of Occupational Health (FI)
- University College London (GB)
- Inserm (FR)
- Region Stockholm (SE)
- Uppsala University (SE)
- Mid Sweden University (SE)
- Stockholm University (SE)
- University of Eastern Finland (FI)
- University of Bristol (GB)
- SomaLogic (United States) (US)
- Sahlgrenska University Hospital (SE)
- ORCID
- Kivimäki, Mika
- Walker, Keenan A
- Nyberg, Solja T
- Mars, Nina
- Vahtera, Jussi
- Suominen, Sakari B
- Lallukka, Tea
- Rahkonen, Ossi
- Pietiläinen, Olli
- Koskinen, Aki
- Väänänen, Ari
- Kalsi, Jatinderpal K
- Goldberg, Marcel
- Zins, Marie
- Alfredsson, Lars
- Westerholm, Peter J M
- Theorell, Töres
- Ervasti, Jenni
- Oksanen, Tuula
- Sipilä, Pyry N
- Williams, Stephen A
- Livingston, Gill
- Gottesman, Rebecca F
- Zetterberg, Henrik
- Lindbohm, Joni V
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2021-08-18
- Volume
- 374
- Pages
- n1804
- ISSN
- 1756-1833 (ISSN-L)
- PMC
- PMC8372196
- OpenAlex
- W3195219680
- Cited by
- 99
- References
- 12
- Citations by year
- 2026: 18 · 2025: 30 · 2024: 22 · 2023: 20 · 2022: 6 · 2021: 3
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- BMJ (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- UCL Discovery (University College London) (submittedVersion)
- Työväentutkimus Vuosikirja (submittedVersion)
- Funders
- Alzheimer's Drug Discovery Foundation (2016862, 201809, 201809–2016862)
- Wellcome Trust (221854, 221854/Z/20/Z, 311492, 329202, R01AG056477)
- University College London
- Academy of Finland (RF1AG062553, 311492, 331671, 330527, 329240, 329,202, #1294514, 321409, 75021)
- Juho Vainion Säätiö (1294514)
- Vetenskapsrådet (681712, 2018-, 2018-02532)
- NordForsk (RF1AG062553, 75021, 311492)
- UK Dementia Research Institute
- National Institutes of Health (HHSN268201100012C, HHSN268201100008C, HHSN268201100006C, HHSN26820- 1100005C, HHSN268201100007C, HHSN268201100011C, HHSN268201100009C, S011676, 2U01-HL-096902, 2U01-HL-096899)
- Medical Research Council (S011676, MR/S011676/1, MR/R024227/1, RF1AG062553, 311492, MRC S011676)
- National Institute on Aging (AG052573, RF1AG062553, AG064122, 2U01HL096899, R01AG056477, K24AG052573, U01 2U01HL096812, 2U01HL096902, 311492, P30AG066507)
- National Heart, Lung, and Blood Institute (HHSN268201 100012C, HHSN268201100007C, HHSN2682 01100008C, 2U01HL096899, HH-SN-268201100006C, HHSN268201100011C, HSN268201100010C, U01 2U01HL096812, HHSN268201100005C, U01HL096814, HHSN26820 1100009C, U01HL096917, 2U01HL096902, U01HL096812)
- National Institute on Deafness and Other Communication Disorders (2U01HL096899, U01 2U01HL096812, 2U01HL096902)
- H2020 European Research Council (681712)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Cognitive Abilities and Testing
- Health Sciences › Health Professions › General Health Professions › Workplace Health and Well-being
- Keywords
- dementia risk, plasma proteins, protein pathways, Slit2, axonogenesis, synaptogenesis, neuroinflammation, neurodegeneration, job-exposure matrix, individual patient data meta-analysis, cardiometabolic disease, dementia prevention
- MeSH terms
- Aged, Aged, 80 and over, Blood Proteins, Dementia, Europe, Female, United Kingdom, Humans, Male, Neuropsychological Tests, Occupational Diseases, Occupations, Prospective Studies, Risk Factors, United States, Incidence, Proportional Hazards Models, Workplace, Sedentary Behavior
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review